COSMO — Farmacosmo SpA Balance Sheet
0.000.00%
- €26.16m
- €28.30m
- €71.21m
- 43
- 42
- 26
- 25
Annual balance sheet for Farmacosmo SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.942 | 2.06 | 1.41 | 6.85 | 5.07 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.51 | 4.62 | 5.71 | 10.2 | 6.82 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.98 | 7.66 | 9.26 | 21.8 | 20.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.195 | 0.193 | 0.296 | 0.483 | 0.494 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 4.78 | 8.71 | 10.8 | 39.2 | 36.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.25 | 7.95 | 8.98 | 18.9 | 15.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.4 | 8.15 | 9.8 | 21.8 | 23.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 0.381 | 0.553 | 0.967 | 17.4 | 12.9 |
Total Liabilities & Shareholders' Equity | 4.78 | 8.71 | 10.8 | 39.2 | 36.4 |
Total Common Shares Outstanding |